Chloroquine Phosphate Tablets IP 100 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Chloroquine Phosphate Tablets IP 100 mg | Manufacturer
Product image for Chloroquine Phosphate Tablets IP 100 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Chloroquine Phosphate |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049056 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Antimalarial drugs |
| Subcategory | Antimalarial drugs |
| Active Ingredient | Chloroquine Phosphate |
| Strength | 100 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antimalarial drugs |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Chloroquine Phosphate Tablets IP 100 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Acute oral treatment of uncomplicated malaria caused by Plasmodium falciparum. 2. Treatment of mixed Plasmodium infections and chloroquine-resistant malaria strains in endemic regions. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Chloroquine Phosphate Tablets IP 100 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Chloroquine Phosphate Tablets IP 100 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Chloroquine Phosphate Tablets IP 100 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Chloroquine Phosphate Tablets IP 100 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally with meals or full-fat milk to maximize therapeutic systemic absorption. Take exactly as prescribed for the complete 3-day treatment schedule without missing any doses. | ||||||||||||||||||||||||
| Side Effects | Common: Headache, dizziness, anorexia, nausea, abdominal discomfort, fatigue. Uncommon: Pruritus, sleep disturbances, palpitation, arthralgia, vomiting. Rare: Cardiac conduction abnormalities (QTc prolongation), hematologic cytopenias. | ||||||||||||||||||||||||
| Warnings and Precautions | Not for Prophylaxis: Indicated solely for curative therapy of acute uncomplicated malaria. Severe Malaria Alert: If signs of complicated or cerebral malaria emerge, transfer immediately to parenteral therapy. Cardiac Monitoring: Caution in patients with preexisting cardiac arrhythmias. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Chloroquine Phosphate or related antimalarial compounds. 2. Severe malaria presenting with coma, severe acidosis, or pulmonary edema. 3. Congenital prolonged QT syndrome or clinically significant cardiac arrhythmias. | ||||||||||||||||||||||||
| Drug Interactions | 1. Strong CYP3A4 Inducers/Inhibitors: Alter systemic exposure of active antimalarial moieties. 2. QTc-Prolonging Drugs (Antiarrhythmics, Macrolides): Heightened risk of ventricular dysrhythmias. 3. Antiretrovirals: Variable pharmacokinetic interactions; monitor clinical parasitic response. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Chloroquine Phosphate Tablets IP 100 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Chloroquine Phosphate Tablets IP 100 mg? | The source specification is IP; confirm the required standard before contracting. |
| What quality tests are applicable for Chloroquine Phosphate Tablets IP 100 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Chloroquine Phosphate Tablets IP 100 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Chloroquine Phosphate Tablets IP 100 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Chloroquine Phosphate Tablets BP 160 mg + 100 mg ExporterView product →
✚
Chloroquine Phosphate Tablets BP 160 mg + 100 mg ManufacturerView product →
✚
Chloroquine Phosphate Tablets BP 160 mg + 100 mg SupplierView product →
✚
Chloroquine Phosphate Tablets BP 250 mg ExporterView product →
✚
Chloroquine Phosphate Tablets BP 250 mg ManufacturerView product →
✚
Chloroquine Phosphate Tablets BP 250 mg SupplierView product →
✚
Chloroquine Phosphate Tablets IP 100 mg ExporterView product →
✚
Chloroquine Phosphate Tablets IP 100 mg SupplierView product →
✚
Chloroquine Phosphate Tablets IP 250 mg ExporterView product →
✚
Chloroquine Phosphate Tablets IP 250 mg ManufacturerView product →
✚
Chloroquine Phosphate Tablets IP 250 mg SupplierView product →
✚
Amodiaquine Hydrochloride Tablets USP 100 mg ExporterView product →
